drug
discoveri
process
new
candid
medic
discov
initi
began
random
search
therapeut
agent
plant
anim
natur
occur
miner
burger
depend
materia
medica
establish
medicin
men
priest
era
follow
origin
classic
pharmacolog
desir
therapeut
effect
small
molecul
test
intact
cell
whole
organ
later
advent
human
genom
sequenc
revolution
drug
discoveri
process
develop
drug
discoveri
also
known
revers
pharmacolog
reli
hypothesi
modul
activ
specif
protein
therapeut
effect
protein
drug
bind
interact
also
refer
target
reductionist
approach
small
molecul
chemic
librari
screen
effect
target
known
predict
function
hacker
et
al
small
molecul
select
particular
target
modif
carri
atom
level
amelior
lockandkey
interact
onedrugonetargetonetherapeut
approach
follow
last
sever
decad
inform
technolog
revolut
end
centuri
metamorphos
drug
discoveri
process
well
clark
pickett
advanc
omic
technolog
time
use
develop
strategi
differ
phase
drug
research
buriani
et
al
comput
power
implement
discoveri
process
predict
druglik
newli
design
discov
compound
ligandprotein
dock
predict
bind
affin
small
molecul
protein
threedimension
structur
silico
tool
develop
predict
pharmacolog
properti
drug
molecul
absorpt
distribut
metabol
excret
toxicityabbrevi
togeth
admet
van
de
waterbeemd
gifford
clark
grootenhui
technolog
advanc
trigger
discoveri
effort
direct
discov
specif
magic
bullet
complet
holist
approach
tradit
medicin
magic
bullet
approach
current
declin
phase
major
limit
drug
discoveri
approach
side
effect
inabl
tackl
multifactori
diseas
mainli
due
linear
approach
peak
histor
time
drug
discoveri
develop
natur
drug
play
signific
role
due
superior
chemic
divers
safeti
synthet
compound
librari
zimmermann
et
al
current
estim
one
hundr
new
natur
lead
clinic
develop
harvey
mani
activ
compound
bioactiv
tradit
medicin
sourc
could
serv
good
start
compound
scaffold
ration
drug
design
natur
product
normal
act
modul
multipl
target
rather
singl
highli
specif
target
drug
discoveri
develop
technolog
use
synthes
highli
specif
monotarget
molecul
mimic
bioactiv
natur
compound
rather
understand
rational
behind
synergist
action
develop
method
isol
bioactiv
natur
resourc
research
understand
diseas
due
dysfunct
multipl
protein
thu
import
address
multipl
target
eman
syndromerel
metabol
cascad
holist
manag
effect
achiev
therefor
necessari
shift
strategi
one
focus
singletarget
new
chemic
entiti
one
multipletarget
synergist
formulationdiscoveri
approach
tempt
research
world
go
back
extens
explor
natur
sourc
modern
pharmacolog
begun
renew
research
focu
indic
need
rediscov
drug
discoveri
process
integr
tradit
knowledg
stateoftheart
technolog
patwardhan
new
disciplin
call
network
pharmacolog
np
emerg
attempt
understand
drug
action
interact
multipl
target
hopkin
use
comput
power
systemat
catalogu
molecular
interact
drug
molecul
live
cell
np
appear
import
tool
understand
underli
complex
relationship
botan
formula
whole
bodi
berger
iyengar
also
attempt
discov
new
drug
lead
target
repurpos
exist
drug
molecul
differ
therapeut
condit
allow
unbias
investig
potenti
target
space
kibbl
et
al
howev
effort
requir
guidanc
select
right
type
target
new
scaffold
drug
molecul
tradit
knowledg
play
vital
role
process
formul
discoveri
repurpos
exist
drug
combin
advanc
system
biolog
np
might
possibl
ration
design
next
gener
promiscu
drug
cho
et
al
hopkin
ellingson
et
al
np
analysi
open
new
therapeut
option
also
aim
improv
safeti
efficaci
exist
medic
postgenom
era
wit
rapid
develop
comput
biolog
techniqu
analyz
explor
exist
biolog
data
key
aim
postgenom
biomed
research
systemat
catalogu
molecul
interact
within
live
cell
essenti
understand
molecul
interact
among
determin
function
immens
complex
machineri
isol
surround
cell
led
emerg
advanc
network
biolog
indic
cellular
network
govern
univers
law
offer
new
conceptu
framework
could
potenti
revolution
view
biolog
diseas
patholog
centuri
oltvai
first
decad
centuri
sever
approach
biolog
network
construct
put
forward
use
comput
method
literatur
mine
especi
understand
relat
diseas
phenotyp
genotyp
consequ
lmma
literatur
mine
microarray
analysi
novel
approach
reconstruct
gene
network
combin
literatur
mine
microarray
analysi
propos
li
et
al
huang
li
global
network
first
deriv
use
cooccurr
method
refin
use
microarray
data
lmma
biolog
network
approach
enabl
research
keep
date
relev
literatur
special
biolog
topic
make
sens
relev
largescal
microarray
dataset
also
lmma
serv
use
tool
construct
specif
biolog
network
experiment
design
represent
enabl
system
recognit
specif
diseas
context
complex
gene
interact
help
studi
regul
variou
complex
biolog
physiolog
patholog
system
signific
accumulateddata
integr
appreci
pharmacologist
began
look
beyond
classic
lockandkey
concept
far
intric
pictur
drug
action
becam
clear
postgenom
era
global
map
pharmacolog
space
uncov
promiscu
specif
bind
chemic
one
target
paolini
et
al
multipl
key
singl
lock
way
singl
key
fit
multipl
lock
similarli
ligand
might
interact
mani
target
target
may
accommod
differ
type
ligand
refer
polypharmacolog
concept
network
biolog
use
integr
data
drugbank
valentini
omim
hamosh
et
al
onlin
catalog
human
gene
genet
disord
understand
industri
trend
properti
drug
target
studi
drug
target
relat
diseasegen
product
way
first
drugtarget
network
construct
isol
bipartit
node
expect
base
exist
onedrugonetargetonediseas
approach
rather
author
observ
rich
network
polypharmacolog
interact
drug
target
yildirim
et
al
overabund
followon
drug
drug
target
alreadi
target
protein
observ
suggest
need
upgrad
singletarget
singledrug
paradigm
singleprotein
singlefunct
relat
limit
accur
describ
realiti
cellular
process
advanc
system
biolog
led
realiz
complex
diseas
effect
treat
intervent
singl
protein
made
drug
research
accept
concept
polypharmacolog
previous
thought
undesir
properti
need
remov
reduc
produc
clean
drug
act
singletarget
accord
network
biolog
simultan
modul
multipl
target
requir
modifi
phenotyp
develop
method
aid
polypharmacolog
help
improv
efficaci
predict
unwant
offtarget
effect
hopkin
hopkin
hopkin
observ
network
biolog
polypharmacolog
illumin
understand
drug
action
introduc
term
network
pharmacolog
distinct
new
approach
drug
discoveri
enabl
paradigm
shift
highli
specif
magic
drug
discoveri
multitarget
drug
discoveri
np
potenti
provid
new
treatment
multigen
complex
diseas
lead
develop
etherapeut
ligand
formul
custom
complex
indic
everi
diseas
type
expand
futur
lead
custom
person
therapeut
integr
network
biolog
polypharmacolog
tackl
two
major
sourc
attrit
drug
develop
efficaci
toxic
also
integr
hold
promis
expand
current
opportun
space
druggabl
target
hopkin
propos
np
next
paradigm
drug
discoveri
polypharmacolog
expand
space
drug
discoveri
approach
hopkin
suggest
three
strategi
design
multitarget
therapi
first
prescrib
multipl
individu
medic
multidrug
combin
cocktail
patient
complianc
danger
interact
would
expect
drawback
method
second
proposit
develop
multicompon
drug
formul
chang
metabol
bioavail
pharmacokinet
formul
well
safeti
would
major
concern
approach
third
strategi
design
singl
compound
select
polypharmacolog
accord
hopkin
third
method
advantag
would
eas
dose
studi
also
regulatori
barrier
singl
compound
fewer
compar
formul
excel
exampl
metformin
firstlin
drug
type
ii
diabet
found
cancerinhibit
properti
leung
et
al
follow
year
wit
applic
research
np
integr
network
biolog
polypharmacolog
comput
framework
base
regress
model
integr
human
interact
diseas
phenotyp
similar
known
associ
captur
complex
relationship
phenotyp
genotyp
propos
base
assumpt
phenotyp
similar
diseas
caus
function
relat
gene
tool
name
cipher
correl
protein
interact
network
phenotyp
network
predict
diseas
gene
develop
predict
priorit
diseasecaus
gene
wu
et
al
cipher
help
uncov
known
diseas
gene
predict
novel
suscept
candid
anoth
applic
studi
predict
human
diseas
landscap
exploit
studi
relat
gene
relat
phenotyp
cluster
togeth
molecular
interact
network
facilit
discoveri
diseas
gene
help
analyz
cooper
among
gene
later
cipherhit
hittingtimebas
method
measur
global
close
two
node
heterogen
network
develop
yao
et
al
network
explor
use
method
detect
gene
relat
particular
phenotyp
gene
cluster
extens
use
identifi
respons
gene
modul
gene
network
aim
provid
use
resourc
understand
physiolog
respons
gu
et
al
np
also
use
develop
biomark
lu
et
al
network
mirna
target
construct
refin
studi
data
specif
diseas
process
integr
literatur
mine
use
develop
potent
mirna
marker
diseas
np
also
use
develop
drug
comodul
zhao
li
initi
drugdiseas
network
construct
inform
gather
databas
follow
integr
gene
data
gene
close
studi
develop
mathemat
model
network
infer
associ
multipl
gene
diseas
target
share
drug
diseas
kind
network
give
insight
new
drugdiseas
associ
molecular
connect
progress
period
network
biolog
natur
product
gain
import
chemic
space
drug
discoveri
econom
design
synthes
natur
benefit
evolut
wetzel
et
al
research
began
analyz
logic
behind
tradit
medicin
system
devis
comput
way
eas
analysi
comprehens
herbal
medicin
inform
system
develop
integr
inform
anticanc
herbal
recip
use
treatment
differ
type
cancer
clinic
individu
ingredi
small
organ
molecul
isol
herbal
medicin
fang
et
al
system
develop
use
oracl
databas
internet
technolog
facilit
promot
scientif
research
herbal
medicin
follow
develop
mani
databas
serv
sourc
botan
inform
power
tool
provid
bridg
tradit
medicin
modern
molecular
biolog
kind
databas
tool
made
research
conceiv
idea
np
botan
formul
understand
underli
mechan
tradit
medicin
refer
network
ethnopharmacolog
network
techniqu
network
ethnopharmacolog
nep
patwardhan
chandran
shao
li
pioneer
endeavor
propos
network
tool
explain
zheng
syndrom
tradit
chines
medicin
tcm
multipletarget
mechan
tcm
li
li
et
al
tri
provid
molecular
basi
concept
zheng
use
neuroendocrineimmun
nei
network
zheng
basic
unit
key
concept
tcm
theori
also
use
guidelin
diseas
classif
tcm
hot
han
zheng
mandarin
cold
zheng
two
status
zheng
therapeut
direct
use
herb
tcm
chines
herb
classifi
use
remedi
hot
zheng
herb
use
remedi
cold
zheng
accord
author
hormon
may
relat
hot
zheng
immun
factor
may
relat
cold
zheng
may
interconnect
neurotransmitt
studi
provid
method
approach
understand
tcm
within
framework
modern
scienc
later
reconstruct
nei
network
ad
multilay
inform
includ
data
avail
kegg
databas
relat
signal
transduct
metabol
pathway
interact
transcript
factor
micro
rna
regul
also
connect
drug
diseas
multilay
interact
studi
cold
zheng
emphas
relat
energi
metabol
tightli
correl
gene
neurotransmitt
hormon
cytokin
nei
interact
network
et
al
anoth
databas
tcmgenedit
provid
inform
tcm
gene
diseas
tcm
effect
tcm
ingredi
mine
vast
amount
biomed
literatur
would
facilit
clinic
research
elucid
possibl
therapeut
mechan
tcm
gene
regul
fang
et
al
studi
combin
rule
tcm
formula
herb
network
creat
use
collateralsrel
formula
develop
distancebas
mutualinform
model
dmim
uncov
combin
rule
dmim
use
mutualinform
entropi
herb
distanc
measur
tendenc
two
herb
form
herb
pair
experiment
evalu
combin
herb
angiogenesi
understand
combin
rule
herb
formula
help
modern
tradit
medicin
also
help
develop
new
formula
base
current
requir
network
paradigm
propos
first
time
understand
synergist
combin
algorithm
term
nim
network
identif
multicompon
synergi
also
develop
step
facilit
develop
multicompon
therapeut
use
tradit
wisdom
innov
way
studi
molecular
mechan
tcm
propos
time
integr
tcm
experiment
data
microarray
gene
express
data
wen
et
al
demonstr
exampl
siwutang
formula
studi
rather
uncov
molecular
mechan
action
method
would
help
identifi
new
health
benefit
tcm
initi
year
second
decad
centuri
wit
network
ethnopharmacolog
explor
tcm
formul
scope
new
area
attract
scientist
hope
nep
could
provid
insight
multicompound
drug
discoveri
could
help
overcom
current
impass
drug
discoveri
patwardhan
nep
use
studi
antiinflammatori
mechan
qingfei
xiaoyan
tcm
predict
result
use
design
experi
analyz
data
experiment
confirm
predict
result
provid
effect
strategi
studi
tradit
medicin
potenti
tcm
formul
multipl
compound
drug
candid
studi
use
tcm
formul
base
np
tcm
formul
studi
way
list
tabl
construct
databas
contain
natur
product
structur
follow
dock
target
protein
fdaapprov
drug
show
amount
space
share
chemic
space
natur
product
fda
drug
gu
et
al
moleculardock
techniqu
play
major
role
np
interact
bioactiv
molecular
target
analyz
techniqu
molecular
nep
use
tool
comput
elucid
combinatori
effect
tradit
medicin
interven
diseas
network
gu
et
al
approach
combin
np
pharmacokinet
propos
studi
materi
basi
tcm
formul
pei
et
al
extrapol
studi
tradit
medicin
formul
well
cancer
research
numer
natur
product
demonstr
anticanc
potenti
natur
product
gain
attract
anticanc
research
show
favor
profil
term
absorpt
metabol
bodi
low
toxic
studi
known
bioactiv
dock
properti
interact
cancer
target
luo
et
al
infer
mani
bioactiv
target
multipl
ejiao
slurri
regul
cancer
cell
differenti
growth
prolifer
apoptosi
show
adjuv
therapeut
effect
enrich
blood
increas
immun
xu
et
al
xiaochaihu
decoct
da
chaihudecoct
xchd
treat
diseas
accompani
symptom
altern
fever
chill
desir
food
drink
dri
pharynx
dchd
treat
symptom
full
pain
abdomen
constip
dragon
blood
use
coliti
act
interact
put
target
xu
et
al
protein
target
thu
link
mani
type
cancer
np
coupl
sophist
spectroscop
analysi
ultraperform
liquid
mass
spectroscopi
uplcesimsm
use
approach
studi
absolut
molecular
mechan
action
botan
formul
base
constitu
bioactiv
xu
et
al
analysi
shown
botan
formul
effect
correspond
market
interact
indic
potenti
np
better
understand
power
botan
formul
develop
effici
econom
treatment
option
holist
approach
botan
formul
better
explain
np
studi
report
properti
exemplifi
tcm
formul
viral
infecti
diseas
formul
target
protein
viral
infect
cycl
also
regul
protein
host
defens
system
thu
act
distinct
manner
uniqu
properti
formul
highli
effici
strengthen
broad
nonspecif
antipathogen
action
thu
networkbas
multitarget
drug
develop
test
efficaci
formul
identifi
isol
major
bioactiv
redevelop
multicompon
therapeut
use
major
bioactiv
base
synerg
leung
et
al
np
also
serv
document
analyz
clinic
prescript
tradit
medicin
practition
tradit
medicin
network
link
bioactiv
clinic
symptom
target
diseas
novel
way
explor
basic
principl
tradit
medicin
luo
et
al
networkbas
approach
provid
systemat
platform
studi
multicompon
tradit
medicin
applic
benefici
modern
platform
recov
tradit
knowledg
also
provid
new
find
use
resolv
current
problem
drug
industri
section
explain
hand
ethnopharmacolog
network
develop
understand
scientif
rational
tradit
medicin
dragon
blood
db
tablet
made
resin
dracaena
spp
daemonorop
spp
croton
spp
pterocarpu
spp
effect
tcm
treatment
coliti
studi
npbase
approach
adopt
provid
new
insight
relat
activ
constitu
molecular
mechan
underli
effect
db
xu
et
al
constitu
chemic
formul
identifi
use
ultraperform
liquid
chromatographyelectrospray
ionizationtandem
mass
spectrometri
method
known
target
identifi
compound
mine
literatur
put
target
predict
help
comput
tool
compound
screen
bioavail
follow
systemat
analysi
known
put
target
coliti
network
evalu
reveal
mechan
action
db
bioactiv
coliti
modul
protein
nodlik
receptor
signal
pathway
fig
antioxid
mechan
zhizidahuang
decoct
approach
treat
alcohol
liver
diseas
elucid
use
np
feng
endotheli
cell
prolifer
assay
perform
antiangiogen
alkaloid
sinomenin
valid
network
identif
multicompon
synergi
nim
predict
studi
aim
evalu
synergist
relationship
differ
pair
therapeut
sinomenin
found
maximum
inhibit
rate
matrin
network
vitro
studi
discoveri
bioactiv
elucid
mechan
action
herbal
formula
qingluoyin
liuweidihuang
pill
use
np
given
insight
design
valid
experi
acceler
process
drug
discoveri
valid
experi
base
network
find
regard
cold
zheng
hot
zheng
rat
model
arthriti
show
cold
herb
tend
affect
hub
node
cold
zheng
network
hot
zhengori
herb
tend
affect
hub
node
hot
zheng
network
np
use
explain
addit
subtract
theori
tcm
two
decoct
xiao
chaihu
da
chaihu
studi
use
np
approach
investig
theori
accord
addit
subtract
theori
addit
remov
one
ingredi
tradit
formul
result
modifi
formula
play
vital
role
individu
medicin
compound
addit
herb
observ
effici
target
fig
addit
compound
found
act
diseas
drug
target
li
et
al
experiment
verif
antithrombot
network
fufang
xueshuantong
fxst
capsul
done
vivo
studi
dissemin
intravascular
coagul
dic
rat
model
success
shown
fxst
significantli
improv
activ
coagul
system
target
four
herb
sheng
et
al
np
analysi
bushenhuoxu
formula
show
six
componentsrhein
tanshinon
iia
curcumin
quercetin
calycosinact
target
treatment
chronic
kidney
diseas
predict
valid
use
unilater
ureter
obstruct
model
observ
even
though
individu
botan
show
signific
decreas
creatinin
level
combin
show
lower
blood
creatinin
urea
nitrogen
level
shi
et
al
antidiabet
effect
gegenqinlian
decoct
investig
use
insulin
secret
assay
model
use
ingredi
show
antidiabet
activ
use
np
studi
li
et
al
confirm
predict
network
liuweidihuang
pill
four
proteinspparg
rara
denot
differ
function
target
differ
group
ingredi
chosen
interact
variou
bioactiv
effect
express
protein
show
np
approach
accur
predict
interact
give
hint
regard
mechan
action
compound
liang
et
al
experiment
result
confirm
core
ingredi
modifi
simiaowan
obtain
network
analysi
significantli
increas
huvec
viabil
attenu
express
prove
effect
gout
treatment
zhao
et
al
role
anthraquinon
flavanol
catechin
epicatechin
therapeut
potenti
rhubarb
renal
interstiti
fibrosi
examin
use
network
analysi
convent
assess
involv
serum
biochemistri
histopatholog
immunohistochem
assay
xiang
et
al
silico
analysi
experiment
valid
demonstr
compound
fructu
schisandra
chinensi
target
np
valuabl
method
studi
synergist
effect
bioactiv
tradit
medicin
formul
experiment
shown
formul
rheumatoid
arthriti
fig
data
network
analysi
shown
formul
act
synergist
nine
categori
target
zi
yu
anoth
network
studi
three
botan
salvia
miltiorrhiza
ligusticum
chuanxiong
panax
notoginseng
coronari
arteri
diseas
cad
display
mode
action
target
common
among
botan
fig
common
target
associ
thrombosi
dyslipidemia
vasoconstrict
inflamm
give
insight
botan
manag
cad
anoth
approach
use
np
construct
network
base
experiment
data
follow
literatur
mine
method
effect
larg
space
data
analysi
help
deriv
mechan
action
formul
network
qishenyiqi
formul
cardioprotect
effect
construct
base
microarray
data
publish
literatur
show
main
compound
found
act
pathway
immun
inflammationrel
li
et
al
mechan
action
bushen
zhuanggu
formul
propos
base
lcmsm
standard
pharmacokinet
analysi
np
pei
et
al
efficaci
shenmai
inject
evalu
use
rat
model
myocardi
infarct
genomewid
transcriptom
experi
follow
np
analysi
overal
trend
eject
fraction
fraction
shorten
consist
index
nri
network
order
develop
ethnopharmacolog
network
explor
exist
databas
gather
inform
regard
bioactiv
target
first
step
inform
targetrel
diseas
tissu
distribut
pathway
also
collect
depend
type
studi
go
undertaken
univers
natur
product
databas
unpd
gu
et
al
one
major
databas
provid
bioactiv
inform
databas
provid
inform
regard
bioactiv
includ
cvdhd
gu
et
al
tcmsp
ru
et
al
tcm
taiwan
sanderson
supernatur
banerje
et
al
dr
duke
phytochem
ethnobotan
databas
duke
beckstromsternberg
molecular
structur
bioactiv
usual
store
sd
file
chemic
inform
smile
inchkey
databas
file
format
use
input
identifi
target
protein
inform
databas
bind
databas
bind
db
liu
et
al
chembl
bento
et
al
databas
predict
target
protein
bind
db
search
exact
similar
compound
databas
retriev
target
inform
compound
similar
search
give
structur
similar
compound
respect
degre
similar
score
queri
structur
inform
regard
annot
predict
target
collect
way
databas
connect
numer
databas
connect
use
extract
inform
regard
target
import
databas
link
bind
db
uniprot
bairoch
et
al
give
inform
relat
protein
gene
reactom
curat
pathway
databas
croft
et
al
kyoto
encyclopedia
gene
genom
kegg
knowledg
base
systemat
analysi
gene
function
pathway
ogata
et
al
therapeut
target
databas
ttd
zhu
et
al
give
fulli
referenc
inform
target
diseas
protein
pathway
inform
correspond
drug
direct
target
diseas
gene
annot
dga
databas
provid
comprehens
integr
annot
human
gene
diseas
network
use
identifi
diseas
type
indic
belong
peng
et
al
human
protein
atla
hpa
databas
et
al
open
databas
show
spatial
distribut
protein
differ
normal
human
tissu
inform
distribut
protein
tissu
gather
hpa
databas
also
give
inform
regard
subcellular
local
protein
class
overal
review
method
implement
np
herb
herbal
formul
also
avail
includ
systemat
review
databas
one
could
use
kibbl
et
al
lagunin
et
al
integr
knowledg
base
help
data
gather
network
pharmacolog
studi
knowledg
base
show
interrelationship
among
databas
fig
count
entiti
bioactiv
target
diseas
vari
base
knowledg
base
reli
data
collect
integr
knowledg
base
overcom
limit
anoth
factor
affect
count
entiti
time
frame
data
collect
chang
occur
due
ongo
period
updat
databas
network
schemat
represent
interact
among
variou
entiti
call
node
pharmacolog
network
node
includ
bioactiv
target
tissu
tissu
type
diseas
diseas
type
pathway
node
connect
line
term
edg
repres
relationship
morri
et
al
build
network
involv
two
opposit
approach
bottomup
approach
basi
establish
biolog
knowledg
topdown
approach
start
statist
analysi
avail
data
detail
level
sever
way
build
illustr
biolog
network
perhap
versatil
gener
way
de
novo
assembl
network
direct
experiment
comput
interact
eg
chemicalgeneprotein
screen
network
encompass
biolog
relev
node
gene
protein
metabolit
connect
biochem
regulatori
modul
pathway
function
unit
give
authent
idea
real
biolog
phenomena
xu
qu
cytoscap
javabas
open
sourc
softwar
platform
shannon
et
al
use
tool
visual
molecular
interact
network
integr
type
attribut
data
addit
basic
set
featur
data
integr
analysi
visual
addit
featur
avail
form
app
includ
network
molecular
profil
analysi
link
databas
addit
cytoscap
number
visual
tool
avail
visual
network
pharmacolog
vnp
special
design
visual
complex
relationship
among
diseas
target
drug
mainli
contain
three
function
modul
drugcentr
targetcentr
diseasecentr
vnp
diseasetargetdrug
databas
document
known
connect
among
diseas
target
usfdaapprov
drug
user
search
databas
use
diseas
target
drug
name
string
chemic
structur
substructur
protein
sequenc
similar
obtain
onlin
interact
network
view
retriev
record
obtain
network
view
node
diseas
target
drug
edg
known
connect
two
connect
map
cmap
tool
allow
user
compar
geneexpress
profil
similar
differ
signatur
transcript
express
profil
small
molecul
transcript
respons
profil
may
lead
discoveri
mode
action
small
molecul
respons
profil
also
compar
respons
profil
drug
cmap
databas
respect
similar
transcript
respons
network
construct
drug
appear
closest
small
molecul
select
better
insight
mode
action
softwar
gephi
explor
platform
network
complex
system
cell
illustr
javabas
tool
special
biolog
process
system
also
use
build
network
ayurveda
indian
tradit
medicin
offer
mani
sophist
formul
use
hundr
year
tradit
knowledg
digit
librari
tkdl
http
wwwtkdlresin
contain
classic
ayurveda
formul
approxim
popularli
use
commun
level
also
overthecount
product
drug
continu
use
home
remedi
prevent
primari
health
care
india
recent
research
carri
explor
ayurved
wisdom
use
np
despit
ayurveda
hold
rich
knowledg
tradit
medicin
equal
greater
tcm
group
examin
use
np
studi
ayurved
formul
wellknown
ayurved
formul
triphala
demonstr
exampl
chandran
et
al
b
chapter
demonstr
applic
np
understand
explor
tradit
wisdom
triphala
model
triphala
one
popular
wide
use
ayurved
formul
triphala
contain
fruit
three
myrobalan
emblica
officinali
eo
amalaki
also
known
phyllanthu
emblica
terminalia
bellerica
tb
vibhitaka
terminalia
chebula
tc
haritaki
triphala
drug
choic
treatment
sever
diseas
especi
metabol
dental
skin
condit
treatment
cancer
baliga
good
effect
health
heart
skin
eye
help
delay
degen
chang
cataract
gupta
et
al
triphala
use
inexpens
nontox
natur
product
prevent
treatment
diseas
vascular
endotheli
growth
factor
angiogenesi
involv
presenc
numer
polyphenol
compound
empow
broad
antimicrobi
spectrum
sharma
triphala
constitu
ayurveda
formul
use
sever
diseas
triphala
combat
degen
metabol
disord
possibl
lipid
peroxid
inhibit
free
radic
scaveng
sabu
kuttan
phase
clinic
trial
healthi
volunt
immunostimulatori
effect
triphala
cytotox
cell
natur
killer
cell
report
phetkat
et
al
triphala
shown
induc
apoptosi
tumor
cell
human
pancrea
vitro
vivo
model
shi
et
al
although
anticanc
properti
triphala
studi
exact
mechan
action
still
known
benefici
role
triphala
diseas
manag
prolif
vitreoretinopathi
also
report
sivasankar
et
al
one
key
ingredi
triphala
amalaki
studi
alreadi
shown
benefici
effect
amalaki
rasayana
suppress
neurodegener
fli
model
huntington
alzheim
diseas
dwivedi
et
al
dwivedi
et
al
triphala
effect
medicin
balanc
three
dosha
consid
good
rejuven
rasayana
facilit
nourish
tissu
dhatu
demonstr
multidimension
properti
triphala
use
human
proteom
diseasom
microbi
proteom
target
network
botan
triphalaeo
tb
tccontain
bioactiv
respect
accord
unpd
data
collect
june
bioactiv
common
among
three
botan
thu
triphala
formul
whole
contain
bioactiv
bioactiv
base
bind
db
search
carri
june
eo
tb
tc
contain
bioactiv
respect
fig
bioactiv
common
among
three
plant
chebulanin
ellag
acid
gallussaeur
methyl
gallat
tannic
acid
bioactiv
inform
basic
step
toward
construct
human
proteom
microbi
proteom
target
network
thirtysix
bioactiv
triphala
shown
interact
human
protein
target
combin
fig
quercetin
ellag
acid
ogalloyl
betadglucos
four
bioactiv
interact
maximum
number
target
respect
major
bioactiv
multitarget
properti
includ
catechin
epicatechin
gallocatechin
kaempferol
major
protein
target
triphala
includ
alkalin
phosphatas
alpl
carbon
anhydras
coagul
factor
x
dna
repair
protein
homolog
protein
betasecretas
plasminogen
activ
inhibitor
prothrombin
regul
gprotein
signal
rg
tissuetyp
plasminogen
activ
plat
tyrosineprotein
phosphatas
nonreceptor
type
target
triphala
associ
diseas
type
includ
diseas
indic
fig
major
diseas
type
triphala
target
associ
includ
cancer
cardiovascular
diseas
nervou
system
diseas
metabol
diseas
analysi
exist
data
indic
target
triphala
bioactiv
involv
differ
type
cancer
make
largest
group
diseas
involv
triphala
target
linkag
interact
bioactiv
target
protein
differ
combin
type
cancer
network
triphala
includ
pancreat
prostat
breast
lung
colorect
gastric
cancer
tumor
quercetin
ellag
acid
prodelphinidin
import
bioactiv
egfr
import
target
play
role
cancer
triphala
show
link
indic
cardiovascular
diseas
bioactiv
target
cardiovascular
diseas
cover
triphala
network
includ
atherosclerosi
myocardi
ischemia
infarct
cerebr
vasospasm
thrombosi
hypertens
bioactiv
play
major
role
cardiovascular
diseas
quercetin
ogalloyl
betadglucos
bellericagenin
prodelphinidin
wherea
target
play
import
role
triphala
network
nervou
system
disord
contain
diseas
signific
one
alzheim
diseas
parkinson
diseas
diabet
neuropathi
retinopathi
subnetwork
bioactiv
interact
target
differ
interact
quercetin
ogalloyl
betadglucos
network
bioactiv
wherea
network
target
plat
aldr
associ
triphala
metabol
disord
determin
six
bioactiv
interact
seven
target
major
metabol
diseas
come
link
obes
diabet
complic
noninsulindepend
diabet
hypercholesterolemia
hyperlipidemia
bioactiv
interact
target
ellag
acid
quercetin
bellericagenin
wherea
highli
network
target
aldr
triphala
bioactiv
also
link
target
diseas
compris
autoimmun
diseas
ulcer
coliti
syndrom
psoriasi
gout
osteoarthr
endometriosi
lung
fibrosi
glomerulonephr
proteometarget
network
triphala
thu
show
abil
synergist
modul
target
associ
diseas
indic
data
gener
avail
inform
includ
onefifth
total
number
bioactiv
logic
analysi
experiment
studi
base
network
result
need
explor
indepth
mechan
action
triphala
research
area
kind
network
give
immens
amount
inform
develop
reveal
real
mysteri
behind
action
tradit
medicin
triphala
also
refer
tridosh
rasayana
balanc
three
constitut
element
life
tonifi
gastrointestin
tract
improv
digest
known
exhibit
antivir
antibacteri
antifung
antiallerg
properti
sharma
amala
jeyaraj
sumathi
parvathi
triphala
mashi
mashi
black
ash
found
nonspecif
antimicrobi
activ
show
dosedepend
inhibit
gramposit
gramneg
bacteria
biradar
et
al
hydroalcohol
aqueou
ether
extract
three
fruit
triphala
report
show
antibacteri
activ
uropathogen
maximum
drug
efficaci
record
alcohol
extract
bag
et
al
prasad
et
al
methanol
extract
triphala
show
presenc
activ
compound
use
gcm
also
show
potent
antibacteri
antifung
activ
amala
jeyaraj
triphala
well
studi
antimicrobi
activ
gramposit
bacteria
gramneg
bacteria
fungal
speci
differ
strain
salmonella
typhi
amala
jeyaraj
sumathi
parvathi
gautam
et
al
srikumar
et
al
triphala
show
signific
antimicrobi
activ
enterococcu
faecali
streptococcu
mutan
grown
tooth
substrat
therebi
make
suitabl
agent
prevent
dental
plaqu
prabhakar
et
al
prabhakar
et
al
applic
triphala
commerci
antimicrobi
agent
explor
signific
reduct
coloni
form
unit
oral
streptococci
observ
triphala
incorpor
mouthwash
formul
srinagesh
et
al
ointment
prepar
triphala
ww
show
signific
antibacteri
wound
heal
activ
rat
infect
staphylococcu
aureu
pseudomona
aeruginosa
streptococcu
pyogen
kumar
et
al
antiinfect
network
triphala
shed
light
efficaci
formul
simultan
target
multipl
microorgan
also
network
provid
inform
regard
novel
combin
explor
combat
problem
multidrug
resist
among
bioactiv
triphala
bioactiv
target
microbi
protein
microorgan
botan
triphalaeo
tb
tccontain
bioactiv
respect
show
interact
microbi
protein
act
modul
target
associ
diseas
leishmaniasi
malaria
tuberculosi
hepat
c
acquir
immunodefici
syndrom
aid
cervic
cancer
candidiasi
lumin
vibriosi
yersiniosi
skin
respiratori
infect
sever
acut
respiratori
syndrom
sar
avian
viral
infect
bacteremia
sleep
sick
anthrax
fig
microorgan
captur
triphala
antiinfect
network
includ
candida
albican
hepat
c
viru
human
immunodefici
viru
human
papillomaviru
type
human
sar
coronaviru
leishmania
amazonensi
mycobacterium
tuberculosi
staphylococcu
aureu
plasmodium
falciparum
yersinia
enterocolitica
mycobacterium
tuberculosi
rmlc
one
four
enzym
involv
synthesi
dtdplrhamnos
precursor
lrhamnos
giraud
et
al
network
show
triphala
potenti
modul
protein
four
bioactiv
punicalin
terflavin
b
gallagylalphabetadglucopyranos
research
new
therapeut
target
mycobacteri
cell
wall
progress
rhamnosyl
residu
play
structur
role
mycobacteri
cell
wall
act
linker
connect
arabinogalactin
polym
peptidoglycan
found
human
give
degre
therapeut
potenti
et
al
triphala
consid
line
develop
novel
antimycobacteri
drug
network
show
potenti
gallussaeur
acid
modul
human
immunodefici
viru
type
revers
transcriptas
inhibit
human
immunodefici
viru
initi
stage
crucial
thu
target
human
immunodefici
viru
type
revers
transcriptas
preiniti
stage
consid
effect
therapi
protein
human
papillomaviru
prevent
apoptosi
figur
microbi
network
triphala
dark
green
veru
botan
triphala
oval
green
node
bioactiv
target
diseas
microorgan
repres
blue
diamond
node
red
triangl
node
pink
octagon
node
respect
infect
cell
bind
fadd
caspas
henc
target
develop
antivir
drug
yuan
et
al
kaempferol
triphala
found
target
protein
potenti
mechan
control
replic
viru
network
also
show
triphala
potenti
act
plasmodium
falciparum
enoylacyl
carrier
protein
reductas
enr
investig
attract
target
due
import
role
membran
construct
energi
product
plasmodium
falciparum
nicola
et
al
parasit
interact
human
erythrocyt
spectrin
membran
protein
protein
aspartyl
aminopeptidas
lauterbach
coetzer
epigallocatechin
epicatechin
modul
epigallocatechin
regul
enoylacyl
carrier
protein
reductas
quercetin
vanil
acid
act
aspartyl
aminopeptidas
epigallocatechin
also
target
protein
reductas
potent
therapeut
target
role
type
ii
fatti
acid
synthas
pathway
plasmodium
falciparum
karmodiya
surolia
epigallocatechin
quercetin
bioactiv
shown
maximum
antimicrobi
target
interact
epigallocatechin
show
interact
acylcarri
protein
reductas
cpg
dna
methylas
enoylacylcarri
protein
reductas
hepat
c
viru
serin
proteas
yoph
plasmodium
falciparum
saccharomyc
cerevisia
spiroplasma
monobia
quercetin
act
proteinas
arginas
betalactamas
ampc
glutathion
reductas
aspartyl
aminopeptidas
malat
dehydrogenas
tyrosineprotein
kinas
transform
protein
fp
escherichia
coli
fujinami
sarcoma
viru
human
sar
coronaviru
sarscov
leishmania
amazonensi
plasmodium
falciparum
saccharomyc
cerevisia
thermu
thermophil
np
gain
impetu
novel
paradigm
drug
discoveri
approach
use
silico
data
fast
becom
popular
due
cost
effici
compar
good
predict
thu
network
analysi
variou
applic
promis
futur
prospect
regard
process
drug
discoveri
develop
np
proven
boon
drug
research
help
reviv
tradit
knowledg
albeit
limit
use
np
nep
studi
bioactiv
form
foundat
tradit
medicin
network
absorpt
distribut
metabol
excret
toxic
effect
admet
paramet
associ
bioactivesformul
administ
form
medicin
need
consid
order
extrapol
silico
cheminformat
data
vitro
vivo
model
silico
tool
offer
predict
paramet
depend
tradit
medicin
gener
accompani
vehicl
deliveri
medicin
vehicl
normal
variou
solventswat
milk
lemon
juic
butter
ghee
clarifi
butter
honeythat
alter
solubl
bioactiv
play
role
regul
admet
paramet
experiment
valid
studi
requir
evalu
principl
tradit
medicin
target
identif
usual
reli
singl
databas
due
limit
avail
databas
free
access
occasion
give
incomplet
result
also
may
novel
target
wait
discov
could
part
mechan
action
bioactiv
deal
discrep
network
multipl
databas
consid
target
identif
integr
databas
serv
similar
function
also
solut
problem
addit
experiment
valid
target
molecul
use
interact
studi
gene
express
studi
provid
concret
testimoni
network
predict
number
tradit
medicin
act
multipl
bioactiv
target
synergi
botan
drug
help
balanc
extrem
pharmacolog
effect
individu
bioactiv
may
interact
bioactiv
variou
target
protein
absorpt
bodi
possibl
enzym
degrad
transport
final
physiolog
effect
crucial
part
tradit
medicin
gilbert
alv
howev
vitro
assay
silico
tool
unabl
give
clear
idea
complet
exact
interact
live
organ
np
cardin
step
toward
understand
mechan
bioactivesformul
give
overview
action
tradit
medicin
use
design
vivo
experi
clinic
trial
save
time
cost
research
invent
observ
formul
work
simultan
modul
multipl
target
modul
includ
activ
target
inhibit
order
understand
complex
synergist
activ
formul
investig
studi
regard
interact
ligand
target
carri
achiev
implement
highthroughput
omic
studi
base
network
data
network
pharmacolog
analysi
present
immens
scope
explor
tradit
knowledg
find
solut
current
problem
challeng
drug
discoveri
industri
nep
also
play
key
role
new
drug
discoveri
drug
repurpos
ration
formul
discoveri
mani
combin
experiment
studi
data
synthesi
use
np
provid
inform
regard
mode
action
tradit
medicin
formul
base
constitu
bioactiv
kind
revers
approach
deduc
molecular
mechan
action
formul
use
modern
integr
technolog
current
network
analysi
base
studi
conduct
literatur
avail
henc
data
inconclus
number
studi
still
underway
novel
data
gener
continu
despit
limit
still
favor
approach
give
insight
hidden
knowledg
ancient
tradit
medicin
wisdom
np
aid
logic
analysi
wisdom
util
understand
knowledg
well
invent
novel
solut
current
pharmacolog
problem
